Jason Benater

Jason Benater currently serves as the Chief Commercial Officer and VP of Commercial Operations at EVERSANA, where responsibilities include leading the commercial launch of an FDA-approved antibiotic and supporting launches in rare orphan diseases. Prior to this role, Jason operated as a self-employed consultant in human and animal health pharmaceuticals from January 2023 to July 2024. Jason's extensive experience at Boehringer Ingelheim from January 1998 to January 2023 includes leadership positions such as Head of U.S. Sales for Companion Animal, where oversight was provided for a team of 512 employees, as well as Vice President and Head of U.S. Commercial & Medical Operations, focusing on the transformation of commercial operations. Jason also played a crucial role in establishing a leadership team as a Commercial Business Director and was recognized for performance in the New England region.